Pharmacist-led home based clinical medication review in stroke

A randomised exploratory trial of a pharmacist-led home based clinical medication review in people after stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN57684399

Enrollment

Registered

2010-05-12

Start date

2009-07-21

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Stroke Research Network

Interventions

Pharmacist home-based clinical medication review in people after stroke versus usual care. The pharmacist visits the intervention group at home and uses the pharmaceutical care plan as a structured ap

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with stroke due for discharge home from acute, rehabilitation or out-patient neurovascular clinic settings 2. Male and female, aged 53-92 years

Exclusion criteria

Exclusion criteria: 1. Discharge to long-term care 2. Terminal serious illness 3. Severe confusion such that the patient does not have capacity to understand or give informed consent 4. Unable to nominate a community pharmacy 5. Severe dysphasia

Design outcomes

Primary

Measure	Time frame
Recruitment rate - eligibility and participation. Measured 6 months after recruitment (due for completion May 2010)	—

Secondary

Measure	Time frame
At 6 months: 1. EUROQoL 2. Beliefs about Medicines Questionnaire 3. Self-reported adherence 4. Medication adherence	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026